Compounds > ibandronic acid
Page last updated: 2024-08-24

ibandronic acid and Hyperparathyroidism

ibandronic acid has been researched along with Hyperparathyroidism in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Algranati, L; Guelman, R; Musso, CG; Pidoux, R; Plantalech, L; RosaDiez, G; Schreck, C; Varela, F1
Bergner, R; Bruckner, D; Henrich, DM; Hoffmann, M; Uppenkamp, M1
Daphnis, E; Karamitopoulou, E; Karkavitsas, N; Katsipi, I; Kyriazis, J; Stratigis, S; Stylianou, K1

Other Studies

3 other study(ies) available for ibandronic acid and Hyperparathyroidism

ArticleYear
Ibandronate improves hyperphosphatemia in dialysis patients with hyperparathyroidism.
    International urology and nephrology, 2004, Volume: 36, Issue:4

    Topics: Diphosphonates; Female; Humans; Hyperparathyroidism; Ibandronic Acid; Middle Aged; Phosphates; Renal Dialysis

2004
[Therapy of hypercalcemia with ibandronate in case of acute renal failure].
    Der Internist, 2006, Volume: 47, Issue:3

    Topics: Acute Kidney Injury; Adenoma; Aged; Bone Density Conservation Agents; Calcium; Creatinine; Diagnosis, Differential; Diphosphonates; Female; Humans; Hypercalcemia; Hyperparathyroidism; Ibandronic Acid; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Recurrence

2006
Parathyromatosis and the challenge of treatment.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2006, Volume: 48, Issue:3

    Topics: Adult; Bone Density Conservation Agents; Diphosphonates; Disease Progression; Ergocalciferols; Female; Humans; Hypercalcemia; Hyperparathyroidism; Ibandronic Acid; Kidney Failure, Chronic; Renal Dialysis; Reoperation

2006